Epizyme (EPZM) PT Lowered to $26 at Wedbush, Following Earnings

May 6, 2021 3:20 PM EDT
Get Alerts EPZM Hot Sheet
Price: $6.59 +2.01%

Rating Summary:
    11 Buy, 4 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 22 | Down: 26 | New: 45
Trade Now! 
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Wedbush analyst David Nierengarten lowered the price target on Epizyme (NASDAQ: EPZM) to $26.00 (from $27.00) while maintaining a Outperform rating.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst PT Change

Related Entities

Earnings